0078-0874 : Kisqali 200 mg Oral Tablet, Film Coated

Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Kisqali
Dosage Form: Oral Tablet, Film Coated
Application #: NDA209092
Rev. Date: 


Markings: RIC;NVR
Shapes:  Round
Colors:  Purple
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0078-0874-63: 3 BLISTER PACK IN 1 CARTON (0078‑0874‑63) > 21 TABLET, FILM COATED IN 1 BLISTER PACK (0078‑0874‑21)

Active Ingredients:

  • Ribociclib

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Crospovidone
  • Hydroxypropyl Cellulose, Unspecified
  • Magnesium Stearate
  • Microcrystalline Cellulose
  • Ferrosoferric Oxide
  • Ferric Oxide Red
  • Lecithin, Soybean
  • Polyvinyl Alcohol, Unspecified
  • Talc
  • Titanium Dioxide
  • Xanthan Gum

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Kinase Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0078-0860 Kisqali 200 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0867 Kisqali 200 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation


Scan the QR code below to easily reference this data in the future:

NDC 0078-0874 QR Code

< Prev: 0078-0867Next: 0078-0909 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 August 2018.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA